Hedge Fund - Adage Capital Management

Phil Gross (pictured) and Robert Atchinson's Adage Capital Management recently added about 98,900 shares to its Vitae Pharmaceuticals Inc (NASDAQ:VTAE) holding, which now stands at 1.12 million shares...

Adage Capital Management, founded by Phill Gross and Robert Atchinson, recently disclosed an ownership stake of 2.66 million shares in Five Prime Therapeutics Inc.

According to a recent 13D filing with the SEC, Phill Gross (pictured) and Robert Atchinson's Adage Capital Management has hiked its stake in Olin Corporation (NYSE:OLN) by about 82%, lifting the holding...

Phill Gross and Robert Atchinson of Adage Capital Partners remain bullish on Cynapsus Therapeutics Inc (NASDAQ:CYNA) according to their latest 13G filing with the SEC.

Recently, after compiling the latest 13F filings submitted by hedge funds, we have noticed a lot of similarities between the equity holdings of  Clint Carlson’s Carlson Capital and Phill Gross and...

Phill Gross and Robert Atchinson's Adage Capital Management has inched up its stake in Meridian Bancorp, Inc. (NASDAQ:EBSB) by acquiring some 141,900 shares according to a new 13G filing.

Phil Gross (pictured) and Robert Atchinson's Adage Capital Management recently boosted its stake in Anixter International Inc.

Phill Gross and Robert Atchinson founded Adage Capital Management in 2001 after spending 18 and 10 years respectively at the Harvard Management Company (HMC).

Phill Gross and Robert Atchinson's Adage Capital Management has filed its 13F with the SEC for the reporting period of March 31, with the fund holding a public equity portfolio valued at $41.02 billion...